Pharsight

FIBROGEN PATENTS FACING OPPOSITIONS

Top patents of FIBROGEN facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2322153B1 08 Oct, 2014 Use Of Hif Alpha Stabilizers For Enhancing Erythropoiesis Jun, 2024 4
EP3470397B1 29 Dec, 2021 Crystalline Forms Of A Prolyl Hydroxylase Inhibitor NA 3
EP2872488B1 22 Aug, 2018 Crystalline Forms Of A Prolyl Hydroxylase Inhibitor NA 3
EP3003284B1 12 Feb, 2020 Pharmaceutical Formulations Of A Hif Hydroxylase Inhibitor NA 2
EP2289531B1 04 Jul, 2018 Medicaments For Increasing Endogenous Erythropoietine (Epo) NA 2
EP2298301B2 16 Nov, 2022 Medicaments For Increasing Endogenous Erythropoietin (Epo) NA 1
EP2324834B1 08 May, 2019 Methods Of Increasing Endogenous Erythropoietin (Epo) Dec, 2022 1